GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aelis Farma SA (XPAR:AELIS) » Definitions » Total Liabilities

Aelis Farma (XPAR:AELIS) Total Liabilities : €13.08 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Aelis Farma Total Liabilities?

Aelis Farma's Total Liabilities for the quarter that ended in Dec. 2023 was €13.08 Mil.

Aelis Farma's quarterly Total Liabilities declined from Dec. 2022 (€19.43 Mil) to Jun. 2023 (€16.79 Mil) and declined from Jun. 2023 (€16.79 Mil) to Dec. 2023 (€13.08 Mil).

Aelis Farma's annual Total Liabilities declined from Dec. 2021 (€27.42 Mil) to Dec. 2022 (€19.43 Mil) and declined from Dec. 2022 (€19.43 Mil) to Dec. 2023 (€13.08 Mil).


Aelis Farma Total Liabilities Historical Data

The historical data trend for Aelis Farma's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aelis Farma Total Liabilities Chart

Aelis Farma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial 6.02 7.71 27.42 19.43 13.08

Aelis Farma Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.42 21.26 19.43 16.79 13.08

Aelis Farma Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Aelis Farma's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=10.032+(2.947+-5.6898930012039E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0.102)
=13.08

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=26.281-13.2
=13.08

Aelis Farma's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=10.032+(2.947+-5.6898930012039E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0.102)
=13.08

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=26.281-13.2
=13.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aelis Farma Total Liabilities Related Terms

Thank you for viewing the detailed overview of Aelis Farma's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Aelis Farma (XPAR:AELIS) Business Description

Traded in Other Exchanges
Address
146, rue Leo Saignat, Bordeaux, FRA, 33077
Aelis Farma SA is a biotechnology Company specializing in the research and development of treatment's related to brain diseases.

Aelis Farma (XPAR:AELIS) Headlines

No Headlines